Rozlytrek (entrectinib) is used to treat adrenal cancer, breast cancer, cervical cancer, colon cancer, liver cancer, lung cancer, ovarian cancer, pancrearic cancer, prostate cancer, renal cancer, skin cancer, stomach cancer, testicular cancer, thryoid cancer and uterine cancer. Rozlytrek is a Kinase Inhibitor, which works by preventing cancer cell growth. The most common form of Rozlytrek is a 100mg capsule. It is also available as a 200mg capsule and a cartson of 50, 42mg packets. There are currently no generic alternaitves for Rozlytrek. It may be covered by some Medicare and insurance plans.